{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:27:34Z","timestamp":1791296854087,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/nm.4266","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T16:31:43Z","timestamp":1483979503000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":175,"title":["Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome"],"prefix":"10.1038","volume":"23","author":[{"given":"Jorge","family":"Oller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"M\u00e9ndez-Barbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Josue","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Villahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizet I","family":"Canelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M","family":"Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rut","family":"Alberca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Lozano-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A","family":"Hurl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna","family":"Milewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Salaices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Francisco","family":"Nistal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5870-237X","authenticated-orcid":false,"given":"Luis Jes\u00fas","family":"Jim\u00e9nez-Borreguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8878-1507","authenticated-orcid":false,"given":"Julie","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel R","family":"Campanero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"BFnm4266_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1172\/JCI42014","volume":"120","author":"HC Dietz","year":"2010","unstructured":"Dietz, H.C. TGF-\u03b2 in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J. Clin. Invest. 120, 403\u2013407 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnm4266_CR2","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1172\/JCI69666","volume":"124","author":"EM Gallo","year":"2014","unstructured":"Gallo, E.M. et al. Angiotensin-II-dependent TGF-\u03b2 signaling contributes to Loeys\u2013Dietz syndrome vascular pathogenesis. J. Clin. Invest. 124, 448\u2013460 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFnm4266_CR3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijcard.2011.08.079","volume":"165","author":"M Renard","year":"2013","unstructured":"Renard, M. et al. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF-\u03b2 signaling in FTAAD. Int. J. Cardiol. 165, 314\u2013321 (2013).","journal-title":"Int. J. Cardiol."},{"key":"BFnm4266_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCRESAHA.113.300675","volume":"113","author":"E Gillis","year":"2013","unstructured":"Gillis, E., Van Laer, L. & Loeys, B.L. Genetics of thoracic aortic aneurysm: at the crossroad of transforming-growth-factor-\u03b2 signaling and vascular smooth muscle cell contractility. Circ. Res. 113, 327\u2013340 (2013).","journal-title":"Circ. Res."},{"key":"BFnm4266_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J.P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117\u2013121 (2006).","journal-title":"Science"},{"key":"BFnm4266_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","volume":"103","author":"DS Lim","year":"2001","unstructured":"Lim, D.S. et al. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103, 789\u2013791 (2001).","journal-title":"Circulation"},{"key":"BFnm4266_CR7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","volume":"37","author":"A Forteza","year":"2016","unstructured":"Forteza, A. et al. Efficacy of losartan versus atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur. Heart J. 37, 978\u2013985 (2016).","journal-title":"Eur. Heart J."},{"key":"BFnm4266_CR8","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R.V. et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. N. Engl. J. Med. 371, 2061\u20132071 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4266_CR9","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron, O. et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur. Heart J. 36, 2160\u20132166 (2015).","journal-title":"Eur. Heart J."},{"key":"BFnm4266_CR10","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1128\/MCB.00494-15","volume":"35","author":"J Oller","year":"2015","unstructured":"Oller, J. et al. C\/EBP-\u03b2 and nuclear factor of activated T cells differentially regulate Adamts1 induction by stimuli associated with vascular remodeling. Mol. Cell. Biol. 35, 3409\u20133422 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"BFnm4266_CR11","doi-asserted-by":"publisher","first-page":"23656","DOI":"10.1074\/jbc.M212964200","volume":"278","author":"A Luque","year":"2003","unstructured":"Luque, A., Carpizo, D.R. & Iruela-Arispe, M.L. ADAMTS1 (METH1) inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165. J. Biol. Chem. 278, 23656\u201323665 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm4266_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0925-4773(02)00115-6","volume":"115","author":"SN Thai","year":"2002","unstructured":"Thai, S.N. & Iruela-Arispe, M.L. Expression of ADAMTS1 during murine development. Mech. Dev. 115, 181\u2013185 (2002).","journal-title":"Mech. Dev."},{"key":"BFnm4266_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.athoracsur.2012.10.084","volume":"95","author":"P Ren","year":"2013","unstructured":"Ren, P. et al. ADAMTS1 and ADAMTS4 levels are elevated in thoracic aortic aneurysms and dissections. Ann. Thorac. Surg. 95, 570\u2013577 (2013).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnm4266_CR14","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1074\/jbc.M009737200","volume":"276","author":"JD Sandy","year":"2001","unstructured":"Sandy, J.D. et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441\u2013Ala442 bond, a site that is cleaved by recombinant ADAMTS1 and ADAMTS4. J. Biol. Chem. 276, 13372\u201313378 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnm4266_CR15","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1095\/biolreprod.103.023911","volume":"70","author":"L Mittaz","year":"2004","unstructured":"Mittaz, L. et al. Adamts1 is essential for the development and function of the urogenital system. Biol. Reprod. 70, 1096\u20131105 (2004).","journal-title":"Biol. Reprod."},{"key":"BFnm4266_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nm1536","volume":"13","author":"RD Cohn","year":"2007","unstructured":"Cohn, R.D. et al. Angiotensin II type 1 receptor blockade attenuates TGF-\u03b2-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13, 204\u2013210 (2007).","journal-title":"Nat. Med."},{"key":"BFnm4266_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E.R. et al. Dysregulation of TGF-\u03b2 activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407\u2013411 (2003).","journal-title":"Nat. Genet."},{"key":"BFnm4266_CR18","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira, L. et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin 1. Proc. Natl. Acad. Sci. USA 96, 3819\u20133823 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4266_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","volume":"51","author":"RE Pyeritz","year":"2000","unstructured":"Pyeritz, R.E. The Marfan syndrome. Annu. Rev. Med. 51, 481\u2013510 (2000).","journal-title":"Annu. Rev. Med."},{"key":"BFnm4266_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1084\/jem.20110503","volume":"208","author":"V Esteban","year":"2011","unstructured":"Esteban, V. et al. Regulator of calcineurin 1 mediates pathological vascular wall remodeling. J. Exp. Med. 208, 2125\u20132139 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm4266_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys, B.L. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275\u2013281 (2005).","journal-title":"Nat. Genet."},{"key":"BFnm4266_CR22","first-page":"1426","volume":"8","author":"Z Wu","year":"2016","unstructured":"Wu, Z., Ruan, Y., Chang, J., Li, B. & Ren, W. Angiotensin II is related to the acute aortic dissection complicated with lung injury through mediating the release of MMP9 from macrophages. Am. J. Transl. Res. 8, 1426\u20131436 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"BFnm4266_CR23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1002\/emmm.201302842","volume":"5","author":"N M\u00e9ndez-Barbero","year":"2013","unstructured":"M\u00e9ndez-Barbero, N. et al. A major role for RCAN1 in atherosclerosis progression. EMBO Mol. Med. 5, 1901\u20131917 (2013).","journal-title":"EMBO Mol. Med."},{"key":"BFnm4266_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann, U. & Sessa, W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 33, 829\u2013837 (2012).","journal-title":"Eur. Heart J."},{"key":"BFnm4266_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/path.1250","volume":"199","author":"EW Albrecht","year":"2003","unstructured":"Albrecht, E.W., Stegeman, C.A., Heeringa, P., Henning, R.H. & van Goor, H. Protective role of endothelial nitric oxide synthase. J. Pathol. 199, 8\u201317 (2003).","journal-title":"J. Pathol."},{"key":"BFnm4266_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s004240100586","volume":"442","author":"J Pfeilschifter","year":"2001","unstructured":"Pfeilschifter, J., Eberhardt, W. & Beck, K.F. Regulation of gene expression by nitric oxide. Pflugers Arch. 442, 479\u2013486 (2001).","journal-title":"Pflugers Arch."},{"key":"BFnm4266_CR27","doi-asserted-by":"publisher","first-page":"25406","DOI":"10.1074\/jbc.M701001200","volume":"282","author":"C-H Tang","year":"2007","unstructured":"Tang, C.-H., Lu, D.-Y., Tan, T.-W., Fu, W.-M. & Yang, R.-S. Ultrasound induces hypoxia-inducible factor 1 activation and inducible nitric oxide synthase expression through the integrin\u2013integrin-linked kinase\u2013Akt\u2013mammalian target of rapamycin pathway in osteoblasts. J. Biol. Chem. 282, 25406\u201325415 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnm4266_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molcel.2008.09.010","volume":"32","author":"C Partovian","year":"2008","unstructured":"Partovian, C., Ju, R., Zhuang, Z.W., Martin, K.A. & Simons, M. Syndecan 4 regulates subcellular localization of mTOR complex 2 and Akt activation in a PKC-\u03b1-dependent manner in endothelial cells. Mol. Cell 32, 140\u2013149 (2008).","journal-title":"Mol. Cell"},{"key":"BFnm4266_CR29","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1515\/BC.2003.152","volume":"384","author":"H Kleinert","year":"2003","unstructured":"Kleinert, H., Schwarz, P.M. & F\u00f6rstermann, U. Regulation of the expression of inducible nitric oxide synthase. Biol. Chem. 384, 1343\u20131364 (2003).","journal-title":"Biol. Chem."},{"key":"BFnm4266_CR30","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1074\/jbc.272.8.4959","volume":"272","author":"EP Garvey","year":"1997","unstructured":"Garvey, E.P. et al. 1400W is a slow, tight-binding and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J. Biol. Chem. 272, 4959\u20134963 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnm4266_CR31","doi-asserted-by":"publisher","first-page":"34796","DOI":"10.1074\/jbc.M506980200","volume":"280","author":"NV Lee","year":"2005","unstructured":"Lee, N.V. et al. Fibulin 1 acts as a cofactor for the matrix metalloprotease ADAMTS1. J. Biol. Chem. 280, 34796\u201334804 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnm4266_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI8635","volume":"105","author":"T Shindo","year":"2000","unstructured":"Shindo, T. et al. ADAMTS1: a metalloproteinase\u2013disintegrin essential for normal growth, fertility, and organ morphology and function. J. Clin. Invest. 105, 1345\u20131352 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnm4266_CR33","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1093\/hmg\/ddr361","volume":"20","author":"C Le Goff","year":"2011","unstructured":"Le Goff, C. & Cormier-Daire, V. The ADAMTS(L) family and human genetic disorders. Hum. Mol. Genet. 20, R163\u2013R167 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4266_CR34","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s00018-011-0780-9","volume":"68","author":"D Hubmacher","year":"2011","unstructured":"Hubmacher, D. & Apte, S.S. Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin 1: a novel mechanism influencing microfibril assembly and function. Cell. Mol. Life Sci. 68, 3137\u20133148 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnm4266_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/embj.201386369","volume":"33","author":"A Escolano","year":"2014","unstructured":"Escolano, A. et al. Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP1 and p38. EMBO J. 33, 1117\u20131133 (2014).","journal-title":"EMBO J."},{"key":"BFnm4266_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.coph.2013.01.002","volume":"13","author":"X Chen","year":"2013","unstructured":"Chen, X., Lu, H., Rateri, D.L., Cassis, L.A. & Daugherty, A. Conundrum of angiotensin II and TGF-\u03b2 interactions in aortic aneurysms. Curr. Opin. Pharmacol. 13, 180\u2013185 (2013).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnm4266_CR37","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook, J.R. et al. Dimorphic effects of transforming-growth-factor-\u03b2 signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 911\u2013917 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm4266_CR38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajhg.2013.06.019","volume":"93","author":"DC Guo","year":"2013","unstructured":"Guo, D.C. et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am. J. Hum. Genet. 93, 398\u2013404 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnm4266_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cjca.2015.11.004","volume":"32","author":"A Karimi","year":"2016","unstructured":"Karimi, A. & Milewicz, D.M. Structure of the elastin\u2013contractile units in the thoracic aorta and how genes that cause thoracic aortic aneurysms and dissections disrupt this structure. Can. J. Cardiol. 32, 26\u201334 (2016).","journal-title":"Can. J. Cardiol."},{"key":"BFnm4266_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","volume":"16","author":"R Kelwick","year":"2015","unstructured":"Kelwick, R., Desanlis, I., Wheeler, G.N. & Edwards, D.R. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol. 16, 113 (2015).","journal-title":"Genome Biol."},{"key":"BFnm4266_CR41","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan, H.C. et al. Akt-dependent regulation of NF-\u03baB is controlled by mTOR and raptor in association with IKK. Genes Dev. 22, 1490\u20131500 (2008).","journal-title":"Genes Dev."},{"key":"BFnm4266_CR42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbamcr.2013.12.006","volume":"1843","author":"S O'Sullivan","year":"2014","unstructured":"O'Sullivan, S., Medina, C., Ledwidge, M., Radomski, M.W. & Gilmer, J.F. Nitric oxide\u2013matrix metalloproteinase 9 interactions: biological and pharmacological significance\u2014NO and MMP9 interactions. Biochim. Biophys. Acta 1843, 603\u2013617 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm4266_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.matbio.2015.01.005","volume":"44-46","author":"SR Van Doren","year":"2015","unstructured":"Van Doren, S.R. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 44-46, 224\u2013231 (2015).","journal-title":"Matrix Biol."},{"key":"BFnm4266_CR44","unstructured":"Segura, A.M. et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 98, II331\u2013337; disc. II337\u2013338 (1998)."},{"key":"BFnm4266_CR45","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0741-5214(97)70261-1","volume":"25","author":"A Biddinger","year":"1997","unstructured":"Biddinger, A., Rocklin, M., Coselli, J. & Milewicz, D.M. Familial thoracic aortic dilatations and dissections: a case control study. J. Vasc. Surg. 25, 506\u2013511 (1997).","journal-title":"J. Vasc. Surg."},{"key":"BFnm4266_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0003-4975(97)00458-X","volume":"64","author":"LN Girardi","year":"1997","unstructured":"Girardi, L.N. & Coselli, J.S. Inflammatory aneurysm of the ascending aorta and aortic arch. Ann. Thorac. Surg. 64, 251\u2013253 (1997).","journal-title":"Ann. Thorac. Surg."},{"key":"BFnm4266_CR47","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1067\/mtc.2002.121291","volume":"123","author":"M Roth","year":"2002","unstructured":"Roth, M., Lemke, P., Bohle, R.M., Klovekorn, W.P. & Bauer, E.P. Inflammatory aneurysm of the ascending thoracic aorta. J. Thorac. Cardiovasc. Surg. 123, 822\u2013824 (2002).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnm4266_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11427-015-4959-4","volume":"59","author":"Y Gao","year":"2016","unstructured":"Gao, Y. et al. A disintegrin and metalloproteinase with thrombospondin motif 1 (ADAMTS1) expression increases in acute aortic dissection. Sci. China Life Sci. 59, 59\u201367 (2016).","journal-title":"Sci. China Life Sci."},{"key":"BFnm4266_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10016-001-0139-z","volume":"16","author":"JM Johanning","year":"2002","unstructured":"Johanning, J.M. et al. Nitric oxide in experimental aneurysm formation: early events and consequences of nitric oxide inhibition. Ann. Vasc. Surg. 16, 65\u201372 (2002).","journal-title":"Ann. Vasc. Surg."},{"key":"BFnm4266_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1067\/mva.2001.111805","volume":"33","author":"JM Johanning","year":"2001","unstructured":"Johanning, J.M., Franklin, D.P., Han, D.C., Carey, D.J. & Elmore, J.R. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion. J. Vasc. Surg. 33, 579\u2013586 (2001).","journal-title":"J. Vasc. Surg."},{"key":"BFnm4266_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/hc2901.091399","volume":"104","author":"PJ Kuhlencordt","year":"2001","unstructured":"Kuhlencordt, P.J. et al. Accelerated atherosclerosis, aortic aneurysm formation and ischemic heart disease in apolipoprotein E and endothelial nitric oxide synthase double-knockout mice. Circulation 104, 448\u2013454 (2001).","journal-title":"Circulation"},{"key":"BFnm4266_CR52","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/hq0901.095750","volume":"21","author":"JK Lee","year":"2001","unstructured":"Lee, J.K., Borhani, M., Ennis, T.L., Upchurch, G.R. Jr. & Thompson, R.W. Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 21, 1393\u20131401 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnm4266_CR53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0741-5214(03)00148-4","volume":"38","author":"J Zhang","year":"2003","unstructured":"Zhang, J. et al. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J. Vasc. Surg. 38, 360\u2013367 (2003).","journal-title":"J. Vasc. Surg."},{"key":"BFnm4266_CR54","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1161\/01.CIR.101.21.2532","volume":"101","author":"S Fukuda","year":"2000","unstructured":"Fukuda, S. et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 101, 2532\u20132538 (2000).","journal-title":"Circulation"},{"key":"BFnm4266_CR55","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1161\/01.STR.0000102556.55600.3B","volume":"34","author":"N Sadamasa","year":"2003","unstructured":"Sadamasa, N., Nozaki, K. & Hashimoto, N. Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 34, 2980\u20132984 (2003).","journal-title":"Stroke"},{"key":"BFnm4266_CR56","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","volume":"330","author":"J Shores","year":"1994","unstructured":"Shores, J., Berger, K.R., Murphy, E.A. & Pyeritz, R.E. Progression of aortic dilatation and the benefit of long-term \u03b2-adrenergic blockade in Marfan's syndrome. N. Engl. J. Med. 330, 1335\u20131341 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4266_CR57","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.2174\/1381612821666150826093152","volume":"21","author":"J De Backer","year":"2015","unstructured":"De Backer, J. et al. Marfan syndrome and related heritable thoracic aortic aneurysms and dissections. Curr. Pharm. Des. 21, 4061\u20134075 (2015).","journal-title":"Curr. Pharm. Des."},{"key":"BFnm4266_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1172\/JCI200420641","volume":"114","author":"DP Judge","year":"2004","unstructured":"Judge, D.P. et al. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J. Clin. Invest. 114, 172\u2013181 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnm4266_CR59","doi-asserted-by":"publisher","first-page":"10688","DOI":"10.1073\/pnas.92.23.10688","volume":"92","author":"VE Laubach","year":"1995","unstructured":"Laubach, V.E., Shesely, E.G., Smithies, O. & Sherman, P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA 92, 10688\u201310692 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4266","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:00:19Z","timestamp":1684450819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFnm4266"],"URL":"https:\/\/doi.org\/10.1038\/nm.4266","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"assertion":[{"value":"24 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}